Functional somatic syndrome

Last updated

Functional somatic syndrome
Specialty Psychiatry, psychosomatic medicine, psychoneuroendocrinoimmunology
Differential diagnosis Organic/medical illness, primary psychiatric disorders (depression/anxiety with somatic features; psychotic disorders with somatic delusions), functional neurological disorder, somatic symptom disorder, mass psychogenic illness, illness anxiety disorder, Munchausen's and Munchausen's by proxy, deconditioning, malingering
Treatment
Medication

Functional somatic syndrome (FSS) (sometimes termed "non-specific physical disorders") refers to a cluster of chronic conditions, characterized by persistent physical symptoms without demonstrable structural or organic disease despite extensive medical testing. [9]

Contents

Contemporary theories describe the aetiology as involing a dysregulation in the brain-body signaling, which includes negative emotional states pathologically activating somatosensory and nociceptive circuits, generating genuine physical sensations through central sensitization, maladaptive stress response systems and learned neuroplastic rewiring, with symptoms resulting from complex interactions between the autonomic nervous system, hypothalamo-pituitary axis and possibly the immune system, rather than from peripheral tissue damage. [10] [11] [12] [13]

Fibromyalgia, chronic fatigue syndrome (now called ME/CFS) and irritable bowel syndrome and are some of the most common disorders that have been described as FSS conditions, [14] [15] [16] although the classification of ME/CFS as an FSS has been increasingly called into question in the recent years. [17] [18] [19] Functional somatic syndromes are very common, although specific criteria differ, they are estimated to affect about anywhere from 4% to 16% of the general population. [20] [21] [22] [23]

Definition and Terminology

FSS refers to disturbances in bodily functioning where aetiology is unknown. [24] The term ‘functional somatic disorders’ (FSD) was proposed in 2020. [25]

"Medically unexplained physical symptoms" only include symptoms where no explanation is found at all, but not poorly understood syndromes like fibromyalgia or IBS. These symptoms can sometimes be worsened in the presence of mental health problems. [26]

"Persistent physical symptoms" [27] includes FSS situations but also situations where persistent physical symptoms are caused by a known illness, such as arthritis.

In "somatic symptom disorder" chronic physical symptoms, which may or may not be linked to a known illness, coincide with excessive and maladaptive thoughts, emotions, and behaviors connected to those symptoms. In FSS these features are not present.

Classification

Being an umbrella term, the disorder is not encoded in the ICD-11, rather its separate manifestations have specific codes there. Proposals for classifications have been made. [28]

Signs and symptoms

Functional somatic syndromes are characterized by ambiguous, non-specific symptoms that appear in otherwise-healthy people. Overlap in symptomology exists across diagnoses, including gastrointestinal issues, pain, fatigue, cognitive difficulties, and sleep difficulties. Some have proposed to group symptoms into clusters [29] [30] or into one general functional somatic disorder given the finding of correlations between symptoms and underlying etiologies. [31]

FSS conditions

The following conditions are often considered to be representations of the functional somatic syndrome:

Overlap of FSS conditions

A considerable overlap of symptoms exists between the FSS diagnoses, with high rates of comorbidity between them. For example, the prevalence of comorbid FSS diagnoses ranges from 20% to 70%, while comorbid affective disorders with a fibromyalgia diagnosis ranges from 20% to 80%. [39]

Prevalence

Studies have found prevalence in the general population of having at least one FSS of 16.3% (n = 9656), [40] and 9.3% (n = 3054). [41]

Some 10% of the general population, and around 33% of adult patients in clinical populations, suffer from functional somatic symptoms. [42]

Potential causes

A mixture of physical and psychological factors may predict FSS. [9] [28]

Psychological factors

Low-quality evidence suggests that patients with somatic syndromes, such as fibromyalgia and irritable bowel syndrome, tend to have a more frequent history of both physical and sexual abuse prior to the onset of their physiological symptoms. Additionally, patients show higher rates of previous emotional abuse, emotional neglect, and physical neglect when compared to the general population. [43]

Attentional bias has been posited as the psychological mechanism by which trauma and somatic symptoms are tied. [44] [45] [ unreliable medical source? ] Attentional bias refers to the idea that traumatic events can cause individuals to become more attuned to their bodily functions, thus intensifying the perception of pain, fatigue, and other common somatic symptoms. [45] [ unreliable medical source? ] The initial traumatic event is interpreted as a threat to the body, and therefore the stress response of the body takes on a new, heightened awareness to any potential subsequent threats. This attentional bias leads to health anxiety, wherein the patient becomes increasingly concerned that common somatic symptoms are related to a physical disease or injury, and therefore, another potential bodily threat. [44] [ unreliable medical source? ] An initial perception of lost control can further intensify attentional bias; sense of control is negatively associated with symptom reporting, suggesting that somatic symptoms are more closely monitored when psychologically recovering from an incident of lost control. [46] [ unreliable medical source? ] Functional somatic syndromes are thought to be a result of conditioned hyperarousal following a trauma; victims are conditioned to respond more sensitively to the somatic symptoms following a trauma by their attention to and reinforcement of the symptom existence. This feedback loop is similar to that of panic disorder, in which fear of a subsequent panic attack causes an increased hyper-vigilance towards, and exacerbation of, physiological symptoms, such as heart palpitations, dizziness, and breathlessness. [47] [ unreliable medical source? ]

Biological factors

One hypothesis implicates the hypothalamic–pituitary–adrenal axis (HPA axis) in the manifestation of somatic symptoms following trauma. The HPA axis plays a major role in moderating the body's stress response to both emotional and physical pain, relating to both the experience of psychological symptoms prevalent following trauma as well as the physiological symptoms prevalent in FSS conditions. [48] When an individual experiences a traumatic event, the HPA axis causes the increased release of cortisol, activating the sympathetic nervous system and causing negative feedback to be sent to the hypothalamus and pituitary gland. In people who have experienced major trauma, this reaction can become dysfunctional and can cause a chronic decrease in cortisol production, though the rates of this decrease in cortisol levels vary across different types and frequencies of trauma. [49]

Diagnosis

Diagnosis of a FSS is usually a diagnosis of exclusion, where physicians rule out other disorders that could explain the dysfunctions being experienced. [50] The DDx is often complex and involves factual organic pathology, as well as a number of psychiatric disorders, including somatic delusions, primary mood/anxiety disorders with somatic manifestations, somatic symptom disorder, illness anxiety disorder, functional neurological disorder, factitious disorder, and malingering, as well as primary deconditioning.

Management and Treatment

Psychological interventions are considered the primary treatment for functional somatic syndromes, with cognitive behavioral therapy (CBT) representing the most empirically supported approach. Systematic reviews indicate CBT reduces somatic symptom severity and disability through small-to-moderate effect sizes, primarily by modifying maladaptive illness beliefs and reducing avoidance behaviors rather than altering symptom intensity directly. Short-term psychodynamic psychotherapy (STPP) has demonstrated efficacy comparable or superior to CBT in long-term follow-up studies, while third-wave therapies such as mindfulness-based interventions and Acceptance and Commitment Therapy (ACT) target psychological flexibility and experiential avoidance. Psychoeducation regarding the psychophysiological mechanisms of symptoms serves as a foundational component across all modalities, aiming to reframe the patient's understanding of their condition from organic disease to functional dysregulation. [51] [52] [53] [54]

Physical therapies for functional somatic syndromes primarily comprise graded exercise therapy, structured aerobic training, and activity-based rehabilitation programs that aim to reverse deconditioning and reduce symptom-focused inactivity. Graded exercise therapy typically involves individually titrated, stepwise increases in physical activity (e.g., walking, cycling) under supervision, with progression guided by time rather than symptoms to prevent reinforcement of avoidance behavior. Additional components include physiotherapy targeting posture, muscle tension, and pain-modulating movement patterns, as well as occupational therapy interventions that systematically rebuild daily functioning and participation in work and leisure activities. These interventions are predicated on evidence that functional symptoms are maintained by a cycle of inactivity, hypervigilance to bodily sensations, and fear-avoidance, and they therefore emphasize behavioral activation and exposure to normal levels of exertion rather than passive modalities such as rest or purely palliative treatments. [55] [56]

Medications such as antidepressants may play a role. [57] [58] More direct medication has little if any positive long-term impact. [9]

According to guidance from the German Federal Ministry of Health "the extent to which functional somatic syndromes affect people’s lives partly depends on how the people affected deal with them." [9]

History

The term functional somatic syndrome was used in a 1999 paper. [59]

References

  1. Van Dessel N, Den Boeft M, Van Der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, et al. (2014). "Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults". Cochrane Database of Systematic Reviews (11): CD011142. doi:10.1002/14651858.CD011142.pub2. PMC   10984143 . PMID   25362239.{{cite journal}}: CS1 maint: article number as page number (link)
  2. Henningsen P, Zipfel S, Herzog W (2007). "Management of functional somatic syndromes". Lancet (London, England). 369 (9565): 946–955. doi:10.1016/S0140-6736(07)60159-7. PMID   17368156.
  3. Van Dessel N, Den Boeft M, Van Der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, et al. (2014). "Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults". Cochrane Database of Systematic Reviews (11): CD011142. doi:10.1002/14651858.CD011142.pub2. PMC   10984143 . PMID   25362239.{{cite journal}}: CS1 maint: article number as page number (link)
  4. Kleinstäuber M, Witthöft M, Steffanowski A, Van Marwijk H, Hiller W, Lambert MJ (2014). "Pharmacological interventions for somatoform disorders in adults". The Cochrane Database of Systematic Reviews (11): CD010628. doi:10.1002/14651858.CD010628.pub2. PMC   11023023 . PMID   25379990.{{cite journal}}: CS1 maint: article number as page number (link)
  5. Kleinstäuber M, Witthöft M, Steffanowski A, Van Marwijk H, Hiller W, Lambert MJ (2014). "Pharmacological interventions for somatoform disorders in adults". The Cochrane Database of Systematic Reviews (11): CD010628. doi:10.1002/14651858.CD010628.pub2. PMC   11023023 . PMID   25379990.{{cite journal}}: CS1 maint: article number as page number (link)
  6. Kleinstäuber M, Witthöft M, Steffanowski A, Van Marwijk H, Hiller W, Lambert MJ (2014). "Pharmacological interventions for somatoform disorders in adults". The Cochrane Database of Systematic Reviews (11): CD010628. doi:10.1002/14651858.CD010628.pub2. PMC   11023023 . PMID   25379990.{{cite journal}}: CS1 maint: article number as page number (link)
  7. Kleinstäuber M, Witthöft M, Steffanowski A, Van Marwijk H, Hiller W, Lambert MJ (2014). "Pharmacological interventions for somatoform disorders in adults". The Cochrane Database of Systematic Reviews (11): CD010628. doi:10.1002/14651858.CD010628.pub2. PMC   11023023 . PMID   25379990.{{cite journal}}: CS1 maint: article number as page number (link)
  8. Kleinstäuber M, Witthöft M, Steffanowski A, Van Marwijk H, Hiller W, Lambert MJ (2014). "Pharmacological interventions for somatoform disorders in adults". The Cochrane Database of Systematic Reviews (11): CD010628. doi:10.1002/14651858.CD010628.pub2. PMC   11023023 . PMID   25379990.{{cite journal}}: CS1 maint: article number as page number (link)
  9. 1 2 3 4 "Non-specific physical disorders (functional somatic syndromes)". gesund.bund.de. Dec 15, 2023.
  10. Bogaerts K, Van Den Houte M, Jongen D, Ly HG, Coppens E, Schruers K, et al. (2023-08-21). "Brain mediators of negative affect-induced physical symptom reporting in patients with functional somatic syndromes". Translational Psychiatry. 13 (1): 285. doi:10.1038/s41398-023-02567-3. ISSN   2158-3188. PMC   10442365 . PMID   37604880.
  11. Bourke JH, Langford RM, White PD (March 2015). "The common link between functional somatic syndromes may be central sensitisation". Journal of Psychosomatic Research. 78 (3): 228–236. doi:10.1016/j.jpsychores.2015.01.003. ISSN   1879-1360. PMID   25598410.
  12. Barsky AJ, Borus JF (June 1999). "Functional Somatic Syndromes" . Annals of Internal Medicine. 130 (11): 910–921. doi:10.7326/0003-4819-130-11-199906010-00016. ISSN   0003-4819. PMID   10375340.
  13. Burton C, Fink P, Henningsen P, Löwe B, Rief W, EURONET-SOMA Group (2020-03-03). "Functional somatic disorders: discussion paper for a new common classification for research and clinical use". BMC Medicine. 18 (1): 34. doi: 10.1186/s12916-020-1505-4 . ISSN   1741-7015. PMC   7052963 . PMID   32122350.
  14. Häuser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M, Henningsen P (June 2009). "Fibromyalgia syndrome: classification, diagnosis, and treatment". Deutsches Arzteblatt International. 106 (23): 383–391. doi:10.3238/arztebl.2009.0383. ISSN   1866-0452. PMC   2712241 . PMID   19623319.
  15. Lacourt T, Houtveen J, van Doornen L (2013-01-01). ""Functional somatic syndromes, one or many?": An answer by cluster analysis" . Journal of Psychosomatic Research. 74 (1): 6–11. doi:10.1016/j.jpsychores.2012.09.013. ISSN   0022-3999. PMID   23272982.
  16. Hausteiner-Wiehle C, Henningsen P (2014-05-28). "Irritable bowel syndrome: relations with functional, mental, and somatoform disorders". World Journal of Gastroenterology. 20 (20): 6024–6030. doi: 10.3748/wjg.v20.i20.6024 . ISSN   2219-2840. PMC   4033442 . PMID   24876725.
  17. Thoma M, Froehlich L, Hattesohl DB, Quante S, Jason LA, Scheibenbogen C (2023-12-31). "Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients". Medicina (Kaunas, Lithuania). 60 (1): 83. doi: 10.3390/medicina60010083 . ISSN   1648-9144. PMC   10819994 . PMID   38256344.
  18. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC): National Academies Press (US). ISBN   978-0-309-31689-7. PMID   25695122.
  19. Komaroff AL (2019-08-13). "Advances in Understanding the Pathophysiology of Chronic Fatigue Syndrome". JAMA. 322 (6): 499–500. doi:10.1001/jama.2019.8312. ISSN   1538-3598. PMID   31276153.
  20. Madsen MM, Trolle C, Fynne LV, Colombo M, Pedersen RL, Sørensen VN, et al. (November 2025). "Early identification of functional somatic disorders in an internal medicine diagnostic clinic: The DISTRESS trial". Contemporary Clinical Trials. 158 108082. doi: 10.1016/j.cct.2025.108082 . PMID   40972891.
  21. Rometsch C, Mansueto G, Maas Genannt Bermpohl F, Martin A, Cosci F (June 2024). "Prevalence of functional disorders across Europe: a systematic review and meta-analysis". European Journal of Epidemiology. 39 (6): 571–586. doi:10.1007/s10654-024-01109-5. ISSN   0393-2990. PMC   11249491 . PMID   38551715.
  22. Petersen MW, Schröder A, Jørgensen T, Ørnbøl E, Dantoft TM, Eliasen M, et al. (July 2020). "Prevalence of functional somatic syndromes and bodily distress syndrome in the Danish population: the DanFunD study". Scandinavian Journal of Public Health. 48 (5): 567–576. doi:10.1177/1403494819868592. ISSN   1651-1905. PMID   31409218.
  23. Rometsch C, Cosci F, Martin A (July 2024). "Prävalenz von chronischem Schmerz und funktionellen somatischen Syndromen in Deutschland: Systematisches Review und Metaanalyse". Psychotherapie. 69 (4): 217–230. doi:10.1007/s00278-024-00734-5. ISSN   2731-7161.
  24. Donnachie E, Schneider A, Enck P (2020). "Comorbidities of Patients with Functional Somatic Syndromes Before, During and After First Diagnosis: A Population-based Study using Bavarian Routine Data". Scientific Reports. 10 (1) 9810. Bibcode:2020NatSR..10.9810D. doi:10.1038/s41598-020-66685-4. PMC   7299983 . PMID   32555301.
  25. Burton C, Fink P, Henningsen P, Löwe B, Rief W (2020). "Functional somatic disorders: Discussion paper for a new common classification for research and clinical use". BMC Medicine. 18 (1): 34. doi: 10.1186/s12916-020-1505-4 . PMC   7052963 . PMID   32122350.
  26. "Medically unexplained symptoms". nhs.uk. October 15, 2025.
  27. Löwe B, Toussaint A, Rosmalen JG, Huang WL, Burton C, Weigel A, et al. (June 15, 2024). "Persistent physical symptoms: definition, genesis, and management". The Lancet. 403 (10444): 2649–2662. doi:10.1016/S0140-6736(24)00623-8. hdl: 11370/4dab9091-5fd6-47d9-84f8-cbfb2d7b4f76 . PMID   38879263 via www.thelancet.com.
  28. 1 2 Burton C, Fink P, Henningsen P, Löwe B, Rief W (2020). "Functional somatic disorders: discussion paper for a new common classification for research and clinical use - PMC". BMC Medicine. 18 (1): 34. doi: 10.1186/s12916-020-1505-4 . PMC   7052963 . PMID   32122350.
  29. Fink P, Schröder A (May 2010). "One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders". Journal of Psychosomatic Research. 68 (5): 415–426. doi:10.1016/j.jpsychores.2010.02.004. PMID   20403500.
  30. Lacourt T, Houtveen J, van Doornen L (January 2013). ""Functional somatic syndromes, one or many?" An answer by cluster analysis". Journal of Psychosomatic Research. 74 (1): 6–11. doi: 10.1016/j.jpsychores.2012.09.013 . PMID   23272982.
  31. Wessely S, White PD (August 2004). "There is only one functional somatic syndrome". The British Journal of Psychiatry. 185 (2): 95–96. doi: 10.1192/bjp.185.2.95 . PMID   15286058.
  32. Fischer S, Kleinstäuber M, Fiori LM, Turecki G, Wagner J, von Känel R (2023). "DNA Methylation Signatures of Functional Somatic Syndromes: Systematic Review". Psychosomatic Medicine. 85 (8): 672–681. doi: 10.1097/PSY.0000000000001237 . ISSN   1534-7796. PMID   37531610.
  33. 1 2 3 4 5 6 7 8 9 "2.2 The Putative Disappearance of Somatic Manifestations of Hysteria", From Photography to fMRI, transcript Verlag, pp. 219–237, 2022-12-31, doi: 10.1515/9783839461761-009 , ISBN   978-3-8394-6176-1, In the late 1990s, it became a matter of heated debate if hysteria's nosological successors were conceptually and diagnostically distinguishable from a range of possibly related clinical conditions that were equally characterised by the lack of any demonstrable physical abnormality. Jointly referred to as functional somatic syndromes, these conditions include multiple chemical sensitivity, sick building syndrome, chronic fatigue syndrome, fibromyalgia, irritable bowel syndrome, chronic whiplash, chronic Lyme disease, the Gulf War syndrome, food allergies, hypoglycaemia. To this date, the delineation between present-day forms of hysteria and other functional somatic syndromes remains unresolved.{{citation}}: CS1 maint: work parameter with ISBN (link)
  34. Afari N, Ahumada SM, Wright LJ, Mostoufi S, Golnari G, Reis V, et al. (January 2014). "Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis". Psychosomatic Medicine. 76 (1): 2–11. doi:10.1097/PSY.0000000000000010. PMC   3894419 . PMID   24336429.
  35. Joffe AR, Elliott A (2023-01-01). "Long COVID as a functional somatic symptom disorder caused by abnormally precise prior expectations during Bayesian perceptual processing: A new hypothesis and implications for pandemic response". Sage Open Medicine. 11 20503121231194400. doi:10.1177/20503121231194400. ISSN   2050-3121. PMC   10467233 . PMID   37655303.
  36. Mayou R, Farmer A (August 2002). "ABC of psychological medicine: Functional somatic symptoms and syndromes". BMJ. 325 (7358): 265–268. doi:10.1136/bmj.325.7358.265. PMC   1123778 . PMID   12153926.
  37. Manu P, Matthews DA, Lane TJ (March 1993). "Food intolerance in patients with chronic fatigue". The International Journal of Eating Disorders. 13 (2): 203–209. doi:10.1002/1098-108x(199303)13:2<203::aid-eat2260130208>3.0.co;2-u. ISSN   0276-3478. PMID   8477289.
  38. Yantcheva B, Mohr P, Martin M (2016-12-31). "Food intolerance â€" evidence for functional somatic syndrome?". European Health Psychologist: 882. ISSN   2225-6962.
  39. Häuser W, Kosseva M, Üceyler N, Klose P, Sommer C (June 2011). "Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis". Arthritis Care & Research. 63 (6): 808–820. doi: 10.1002/acr.20328 . PMID   20722042.
  40. Petersen MW, Schröder A, Jørgensen T, Ørnbøl E, Dantoft TM, Eliasen M, et al. (July 1, 2020). "Prevalence of functional somatic syndromes and bodily distress syndrome in the Danish population: the DanFunD study". Scandinavian Journal of Public Health. 48 (5): 567–576. doi:10.1177/1403494819868592. PMID   31409218.
  41. Fischer S, Gaab J, Ehlert U, Nater UM (June 1, 2013). "Prevalence, overlap, and predictors of functional somatic syndromes in a student sample". International Journal of Behavioral Medicine. 20 (2): 184–193. doi:10.1007/s12529-012-9266-x. PMID   23055025.
  42. Roenneberg C, Sattel H, Schaefert R, Henningsen P, Hausteiner-Wiehle C (Aug 9, 2019). "Functional Somatic Symptoms". Deutsches Ärzteblatt International. 116 (33–34): 553–560. doi:10.3238/arztebl.2019.0553. PMC   6794707 . PMID   31554544.
  43. Yavne Y, Amital D, Watad A, Tiosano S, Amital H (August 2018). "A systematic review of precipitating physical and psychological traumatic events in the development of fibromyalgia". Seminars in Arthritis and Rheumatism. 48 (1): 121–133. doi:10.1016/j.semarthrit.2017.12.011. PMID   29428291. S2CID   205143853.
  44. 1 2 Golding JM (March 1994). "Sexual assault history and physical health in randomly selected Los Angeles women". Health Psychology. 13 (2): 130–138. doi:10.1037/0278-6133.13.2.130. PMID   8020456.
  45. 1 2 Carleton RN, Duranceau S, McMillan KA, Asmundson GJ (April 2018). "Trauma, Pain, and Psychological Distress". Journal of Psychophysiology. 32 (2): 75–84. doi:10.1027/0269-8803/a000184. ISSN   0269-8803. S2CID   151333609.
  46. Pennebaker JW (1982). The Psychology of Physical Symptoms. doi:10.1007/978-1-4613-8196-9. ISBN   978-1-4613-8198-3.
  47. Antony MM, Brown TA, Craske MG, Barlow DH, Mitchell WB, Meadows EA (September 1995). "Accuracy of heartbeat perception in panic disorder, social phobia, and nonanxious subjects". Journal of Anxiety Disorders. 9 (5): 355–371. doi:10.1016/0887-6185(95)00017-i. ISSN   0887-6185.
  48. Bryant RA (2011-07-15). "Psychological Interventions for Trauma Exposure and PTSD". Post-Traumatic Stress Disorder. John Wiley & Sons, Ltd. pp. 171–202. doi:10.1002/9781119998471.ch5. ISBN   9781119998471.
  49. Weber DA, Reynolds CR (June 2004). "Clinical perspectives on neurobiological effects of psychological trauma". Neuropsychology Review. 14 (2): 115–129. doi:10.1023/b:nerv.0000028082.13778.14. PMID   15264712. S2CID   24172922.
  50. Fischer S, Nater UM (October 4, 2014). "Functional somatic syndromes: asking about exclusionary medical conditions results in decreased prevalence and overlap rates". BMC Public Health. 14 1034. doi: 10.1186/1471-2458-14-1034 . PMC   4286915 . PMID   25280494.
  51. "Management of functional somatic syndromes : The Lancet". www.thelancet.com. Archived from the original on 2010-09-22. Retrieved 2026-01-19.
  52. van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, et al. (2014-11-01). "Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults". The Cochrane Database of Systematic Reviews. 2014 (11): CD011142. doi:10.1002/14651858.CD011142.pub2. ISSN   1469-493X. PMC   10984143 . PMID   25362239.{{cite journal}}: CS1 maint: article number as page number (link)
  53. Henningsen P, Zipfel S, Herzog W (2007-03-17). "Management of functional somatic syndromes". Lancet (London, England). 369 (9565): 946–955. doi:10.1016/S0140-6736(07)60159-7. ISSN   1474-547X. PMID   17368156.
  54. https://psycnet.apa.org/record/2021-33780-001
  55. "Management of functional somatic syndromes : The Lancet". www.thelancet.com. Archived from the original on 2010-09-22. Retrieved 2026-01-19.
  56. Röhricht F, Green C, Filippidou M, Lowe S, Power N, Rassool S, et al. (2024-06-03). "Integrated care model for patients with functional somatic symptom disorder - a co-produced stakeholder exploration with recommendations for best practice". BMC Health Services Research. 24 (1): 698. doi: 10.1186/s12913-024-11130-9 . ISSN   1472-6963. PMC   11145802 . PMID   38831287.
  57. "Somatic Symptom Disorder: What It Is, Symptoms & Treatment". Cleveland Clinic.
  58. "Somatic symptom disorder - Diagnosis and treatment - Mayo Clinic". www.mayoclinic.org.
  59. Barsky AJ, Borus JF (June 1, 1999). "Functional somatic syndromes". Annals of Internal Medicine. 130 (11): 910–921. doi:10.7326/0003-4819-130-11-199906010-00016. PMID   10375340.